ISR IsoRay

Isoray to Present at the H.C. Wainwright BioConnect 2021 Conference

Isoray to Present at the H.C. Wainwright BioConnect 2021 Conference

RICHLAND, Wash., Jan. 07, 2021 (GLOBE NEWSWIRE) --   (NYSE American: ISR), a medical technology company and seed brachytherapy innovator powering expanding treatment options throughout the body, today announced that Chief Executive Officer Lori Woods will present at the H.C. Wainwright BioConnect 2021 Conference. The virtual conference will be held January 11-14, 2021.

The on-demand presentation will be available on Isoray’s Investor Relations section of the Company’s website at at 6:00 a.m. EDT on Monday, January 11, 2021. It will remain available on the website for 90 days.

About Isoray

Isoray, Inc., through its subsidiary, Isoray Medical, Inc. is the sole producer of Cesium-131 brachytherapy seeds, which are expanding brachytherapy options throughout the body. Learn more about this innovative Richland, Washington company and explore the many benefits and uses of Cesium-131 by visiting . Follow us on  and . Join us on .



Contact:
Investor Relations: Mark Levin (501) 255-1910
Media and Public Relations: Sharon Schultz (302) 539-3747
EN
07/01/2021

Underlying

ISRIsoRay

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on IsoRay

 PRESS RELEASE
Free
ISR ISORAY

Perspective Therapeutics to Participate in Upcoming November Conferenc...

Perspective Therapeutics to Participate in Upcoming November Conferences SEATTLE, Oct. 31, 2025 (GLOBE NEWSWIRE) --  ("Perspective" or the "Company") (NYSE AMERICAN: CATX), a radiopharmaceutical development company pioneering advanced treatments for cancers throughout the body, today announced that members of its senior leadership team will participate in and be available for one-on-one meetings with investors at the following upcoming conferences: Truist Securities BioPharma Symposium – 1x1 onlyDate: Thursday, November 6, 2025Location: New York, NY UBS Global Healthcare Conference – Fi...

11h / 8m 1 EN
 PRESS RELEASE
Free
ISR ISORAY

Perspective Therapeutics to Provide Business Highlights and Report Thi...

Perspective Therapeutics to Provide Business Highlights and Report Third Quarter 2025 Financial Results SEATTLE, Oct. 24, 2025 (GLOBE NEWSWIRE) --  ("Perspective" or the "Company") (NYSE AMERICAN: CATX), a radiopharmaceutical development company pioneering advanced treatments for cancers throughout the body, today announced that it will report its third quarter 2025 financial results and provide a business update on Monday, November 10, 2025 after the market closes. The press release will be available on the newsroom section of the Company's website at . About Perspective Therapeutics, ...

October 24, 2025 1 EN
Wedbush Research
  • Wedbush Research
PHM PULTEGROUP INC.
NVCR NOVOCURE LTD.
OSTK OVERSTOCK.COM INC.
ISR ISORAY
AAPL APPLE INC.
RCUS ARCUS BIOSCIENCES
REPL REPLIMUNE GROUP
ARVN ARVINAS HOLDING
IDYA IDEAYA BIOSCIENCES
RVMD REVOLUTION MEDICINES
ORIC ORIC PHARMACEUTICALS
IMNM IMMUNOME
NUVB NUVATION BIO INC (A)
CGEM CULLINAN ONCOLOGY INC
DAWN DAY ONE BIOPHARMACEUTICALS INC
TCRX TSCAN THERAPEUTICS INC
TYRA TYRA BIOSCIENCES INC
NUVL NUVALENT INC
BCAX BICARA THERAPEUTICS INC.
TLX TELIX PHARMACEUTICALS LIMITED
BBOT BRIDGEBIO ONCOLOGY THERAPEUTICS INC
10/21/25 October 21, 2025 1 EN
David Nierengarten ... (+6)
  • David Nierengarten
  • Dennis Pak
  • Geoffrey Von Der Ahe
  • Martin Fan
  • Ritika Das
  • Robert Driscoll
NVCR NOVOCURE LTD.
ISR ISORAY
RCUS ARCUS BIOSCIENCES
REPL REPLIMUNE GROUP
ARVN ARVINAS HOLDING
IDYA IDEAYA BIOSCIENCES
RVMD REVOLUTION MEDICINES
ORIC ORIC PHARMACEUTICALS
IMNM IMMUNOME
NUVB NUVATION BIO INC (A)
CGEM CULLINAN ONCOLOGY INC
DAWN DAY ONE BIOPHARMACEUTICALS INC
TCRX TSCAN THERAPEUTICS INC
TYRA TYRA BIOSCIENCES INC
NUVL NUVALENT INC
BCAX BICARA THERAPEUTICS INC.
TLX TELIX PHARMACEUTICALS LIMITED
BBOT BRIDGEBIO ONCOLOGY THERAPEUTICS INC
10/21/25 October 21, 2025 1 EN
David Nierengarten ... (+3)
  • David Nierengarten
  • Dennis Pak
  • Martin Fan
10/20/25 October 20, 2025 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch